Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382614 · ClinicalTrials.gov registry record · NA
Spiration Valves Against Standard Therapy
A NA study, sponsored by Olympus Corporation of the Americas.
- Terminated
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT02382614: Clinical Trial NA study, sponsored by Olympus Corporation of the Americas.
NCT02382614 is a NA study that was terminated before completion, run by Olympus Corporation of the Americas. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02382614, a NA study, was terminated before completion, sponsored by Olympus Corporation of the Americas.
- TERMINATED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
VAST is a multicenter, prospective, randomized, controlled study designed to evaluate treatment of persistent air leak with the SVS as compared to standard chest tube drainage management and other standard-of-care interventions in the control group. Eligible subjects will be randomized to receive either Spiration Valves (investigational arm) or continue standard-of-care treatment (control arm). Once the air leak has resolved, Spiration Valves should be removed.
Interventions
- DEVICE Spiration Valve System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-05 |
| Est. Completion | 2022-02 |
| Phase | NA |
Why NCT02382614 stopped before completion
NCT02382614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Spiration Valve System is the first listed.
NCT02382614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02382614 about?
NCT02382614 is a clinical study titled "Spiration Valves Against Standard Therapy". VAST is a multicenter, prospective, randomized, controlled study designed to evaluate treatment of persistent air leak with the SVS as compared to standard chest tube drainage management and other standard-of-care interventions in the control group. Eligible subjects will be randomized to receive ei...
What is the current status of trial NCT02382614?
This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2015-05. Estimated completion is 2022-02.
What interventions are being tested in trial NCT02382614?
The interventions under investigation include: Spiration Valve System (DEVICE).
Who is sponsoring clinical trial NCT02382614?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02382614's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia